Overexpression and genetic abnormality of p53 in parathyroid adenomas.
To study the significance of p53 abnormality in parathyroid tumors, 32 parathyroid adenomas and 22 hyperplastic glands from 14 cases of secondary hyperparathyroidism were analysed using immunohistochemistry, polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), single-strand conformation polymorphism (SSCP) and DNA sequencing. Immunohistochemical study revealed p53 overexpression in four parathyroid adenomas, of which two showed diffuse and one showed focal nuclear pleomorphism. Genetic analysis disclosed allelic loss in one, and a point mutation (R290H) and a polymorphism (L257 L) in another of the two other adenomas with diffuse nuclear pleomorphism. No abnormalities were discovered in the other two adenomas, although one had a R72P polymorphism in exon 4. There was no evidence of malignancy of the four tumors in either clinical or pathological terms. None of the 22 hyperplastic glands showed p53 overexpression. These results demonstrate that p53 abnormality can occur in benign parathyroid adenomas and is more prevalent in those with nuclear pleomorphism than in those without.
Kishikawa
S
S
Department of Environmental Pathology, Azabu University, Kanagawa, Japan.
Shan
L
L
Ogihara
K
K
Utsunomiya
H
H
Nakamura
M
M
Nakamura
Y
Y
Naito
A
A
Kakudo
K
K
D000236:Adenoma / Q000235:genetics / Q000378:metabolism*; D000368:Aged; D001483:Base Sequence; D002467:Cell Nucleus / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D005091:Exons; D005260:Female; D017353:Gene Deletion; D015972:Gene Expression Regulation, Neoplastic; D016158:Genes, p53 / Q000235:genetics*; D006801:Humans; D006961:Hyperparathyroidism / Q000235:genetics / Q000378:metabolism*; D007150:Immunohistochemistry; D019656:Loss of Heterozygosity; D008297:Male; D008875:Middle Aged; D010282:Parathyroid Neoplasms / Q000235:genetics / Q000378:metabolism*; D017354:Point Mutation; D011110:Polymorphism, Genetic; D018807:Polymorphism, Single-Stranded Conformational; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
D016159:Tumor Suppressor Protein p53